← All stocks

Cogent Biosciences, Inc.

COGT Scheduled selling only

CIK 0001622229 #1211 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$1.69M

$0.00 on a plan · $1.69M straight out of an exercise

Sold at will

$0.00

0 of 2 sales

Net

−$1.69M

$0.00 against sales at will

By person

8 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Morris Arlene

Director

—

$1.69M (2) scheduled

−$1.69M

0.0000%

$0.00

—

Fairmount Funds Management LLC entity

Director

—

5,503,418

3.17%

$206.60M

−11.6%

Robbins Andrew R

President and CEO

—

657,503

0.3789%

$24.68M

—

Pinnow Cole

Chief Commercial Officer

—

216,650

0.1249%

$8.13M

+5,755%

Robinson John Edward

Chief Scientific Officer

—

140,002

0.0807%

$5.26M

—

Sachs Jessica

Chief Medical Officer

—

133,938

0.0772%

$5.03M

+10,235%

Green John L.

Chief Financial Officer

—

131,834

0.0760%

$4.95M

+3,332%

Kearns Evan

Chief Legal Officer

—

109,398

0.0630%

$4.11M

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 2

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 45,510

History held since 3 Apr 2018